Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD) in later life. We aimed to study the effect of liraglutide intervention on markers of VTE and CVD risk, in PCOS. In a double-blind, placebo-controlled, randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Nylander, Malin, Frøssing, Signe, Kistorp, Caroline, Faber, Jens, Skouby, Sven O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424770/
https://www.ncbi.nlm.nih.gov/pubmed/28119323
http://dx.doi.org/10.1530/EC-16-0113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424770/
https://www.ncbi.nlm.nih.gov/pubmed/28119323
http://dx.doi.org/10.1530/EC-16-0113

Ejemplares similares